TransMedics (TMDX) Revenue Growth (3y) (2021 - 2026)
TransMedics (TMDX) Revenue Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.25 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 47.32 Bn | 43.65 Bn | 1.29 Bn | 10.52% |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.18 Bn | 1.98 Bn | 2.92% |
| 7 | Dexcom | 28.46 Bn | 27.34 Bn | 750.30 Mn | 17.14% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | 0.73% |
| 10 | TransMedics | 2.51 Bn | 2.05 Bn | 101.16 Mn | 61.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.16% |
| Dec 31, 2025 | 72.40% |
| Sep 30, 2025 | 77.58% |
| Jun 30, 2025 | 97.20% |
| Mar 31, 2025 | 108.31% |
| Dec 31, 2024 | 142.35% |
| Sep 30, 2024 | 172.58% |
| Jun 30, 2024 | 136.26% |
| Mar 31, 2024 | 133.20% |
| Dec 31, 2023 | 119.97% |
| Sep 30, 2023 | 102.73% |
| Jun 30, 2023 | 137.37% |
| Mar 31, 2023 | 76.71% |
| Dec 31, 2022 | 73.02% |
| Sep 30, 2022 | 52.76% |
| Jun 30, 2022 | 53.57% |
| Mar 31, 2022 | 50.31% |
| Dec 31, 2021 | 34.09% |
| Sep 30, 2021 | 9.96% |
| Jun 30, 2021 | 43.79% |